Autophagy: A new insight into pathogenesis and treatment possibilities in age-related macular degeneration

Author:

Kubicka-Trząska Agnieszka1,Karska-Basta Izabella1,Żuber-Łaskawiec Katarzyna1

Affiliation:

1. Uniwersytet Jagielloński Collegium Medicum, Wydział Lekarski, Katedra Okulistyki, Klinika Okulistyki i Onkologii Okulistycznej Szpitala Uniwersyteckiego w Krakowie

Abstract

Age-related macular degeneration (AMD) is a significant problem in healthcare, because it is a leading cause of central vision loss in individuals over 50 years old in well-developed countries. Pathogenesis of AMD is multifactorial and still not completely understood. Proven risk factors include the following: natural senescence of retina, oxidative stress, complement activation, chronic subretinal inflammatory reaction, genetic and environmental factors. Data on links between autophagy and AMD development are being raised. Autophagy is a cellular process involving the degradation of long-lived proteins and damaged fragments and components of cells; it is responsible for the maintenance of dynamic intracellular homeostasis and it enables cell survival under stress conditions. Disturbances of autophagy mechanisms, i.e. its activation or inhibition, may lead to the development of many various pathologies. Thus, autophagy plays a dual role, as a mechanism responsible for protecting or killing cells. The paper describes autophagy mechanisms and their role in the natural process of retinal cells senescence and presents the autophagy impairment as a crucial cause of AMD development. We also describe the impact of intravitreal anti-VEGF therapy on retinal autophagy mechanisms and potential new therapeutic modalities for AMD based on autophagy modulation.

Publisher

Walter de Gruyter GmbH

Subject

Infectious Diseases,Microbiology (medical)

Reference104 articles.

1. Abu-Amero K.K., Kondkar A.A., Chalam K.V.: Resveratrol andophthalmic diseases. Nutrients, 2016; 8: 200 2 Agarwal A., Rhoades W.R., Hanout M., Soliman M.K., Sarwar S.,Sadiq M.A., Sepah Y.J., Do D.V., Nguyen Q.D.: Management of neovascularage-related macular degeneration: Current state-of-the-artcare for optimizing visual outcomes and therapies in development.Clin. Ophthalmol., 2015; 9: 1001–1015

2. study: Micronutrients in the treatment of macular degeneration.Adv. Nutr., 2017; 8: 40–53

3. Ardeljan D., Tuo J., Chan C.C.: Carboxyethylpyrrole plasma biomarkersin age-related macular degeneration. Drugs Future, 2011;36: 712–718

4. Bellezza I.: Oxidative stress in age-related macular degeneration:Nrf2 as therapeutic target. Front. Pharmacol., 2018; 9: 1280

5. Bergmann M., Schütt F., Holz F.G., Kopitz J.: Inhibition of theATP-driven proton pump in RPE lysosomes by the major lipofuscinfluorophore A2-E may contribute to the pathogenesis of age-relatedmacular degeneration. FASEB J., 2004; 18: 562–564

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3